BACKGROUND: Severe sepsis and septic shock have a high 30-day mortality (10-50%), but the long-term mortality is not well described. The purpose of this study was to describe long-term mortality among patients with community-acquired severe sepsis or septic shock compared to a population-based reference cohort. METHODS: Two hundred and twelve patients who, within the first 24 h after arrival at the hospital, presented with infection and had failure of at least 1 organ system were included. A population-based reference group of 79,857 patients was identified, and data on comorbidities were extracted from the National Danish Patient Registry. We analyzed the hazard ratio for mortality at predefined intervals. RESULTS: Absolute mortality within the first 30 days was 69/211 (33%, 95% confidence interval (CI) 25-41%), with a cumulative mortality of 121/211 (57%, 95% CI 48-69%) for the entire follow-up. Among septic patients who survived the first 30 days, the mortality hazard ratio was 2.7 (95% CI 1.7-4.3) until day 365, and among septic patients who survived the first year, the 1-4 y mortality hazard ratio was 2.3 (95% CI 1.7-3.3), compared to the community-based reference persons (multivariate Cox regression controlling for age, sex, and Charlson comorbidity index). CONCLUSIONS: Patients with severe sepsis and septic shock who survived the first 30 days had a 2.7 times higher mortality hazard in the first year and a 2.3 times higher mortality hazard in the next 3 y, compared to persons of similar age, sex, and comorbidity level.
BACKGROUND: Severe sepsis and septic shock have a high 30-day mortality (10-50%), but the long-term mortality is not well described. The purpose of this study was to describe long-term mortality among patients with community-acquired severe sepsis or septic shock compared to a population-based reference cohort. METHODS: Two hundred and twelve patients who, within the first 24 h after arrival at the hospital, presented with infection and had failure of at least 1 organ system were included. A population-based reference group of 79,857 patients was identified, and data on comorbidities were extracted from the National Danish Patient Registry. We analyzed the hazard ratio for mortality at predefined intervals. RESULTS: Absolute mortality within the first 30 days was 69/211 (33%, 95% confidence interval (CI) 25-41%), with a cumulative mortality of 121/211 (57%, 95% CI 48-69%) for the entire follow-up. Among septicpatients who survived the first 30 days, the mortality hazard ratio was 2.7 (95% CI 1.7-4.3) until day 365, and among septicpatients who survived the first year, the 1-4 y mortality hazard ratio was 2.3 (95% CI 1.7-3.3), compared to the community-based reference persons (multivariate Cox regression controlling for age, sex, and Charlson comorbidity index). CONCLUSIONS:Patients with severe sepsis and septic shock who survived the first 30 days had a 2.7 times higher mortality hazard in the first year and a 2.3 times higher mortality hazard in the next 3 y, compared to persons of similar age, sex, and comorbidity level.
Authors: Manu Shankar-Hari; Gary S Phillips; Mitchell L Levy; Christopher W Seymour; Vincent X Liu; Clifford S Deutschman; Derek C Angus; Gordon D Rubenfeld; Mervyn Singer Journal: JAMA Date: 2016-02-23 Impact factor: 56.272
Authors: Anna Rautanen; Tara C Mills; Anthony C Gordon; Paula Hutton; Michael Steffens; Rosamond Nuamah; Jean-Daniel Chiche; Tom Parks; Stephen J Chapman; Emma E Davenport; Katherine S Elliott; Julian Bion; Peter Lichtner; Thomas Meitinger; Thomas F Wienker; Mark J Caulfield; Charles Mein; Frank Bloos; Ilona Bobek; Paolo Cotogni; Vladimir Sramek; Silver Sarapuu; Makbule Kobilay; V Marco Ranieri; Jordi Rello; Gonzalo Sirgo; Yoram G Weiss; Stefan Russwurm; E Marion Schneider; Konrad Reinhart; Paul A H Holloway; Julian C Knight; Chris S Garrard; James A Russell; Keith R Walley; Frank Stüber; Adrian V S Hill; Charles J Hinds Journal: Lancet Respir Med Date: 2014-12-18 Impact factor: 30.700
Authors: A Bautista Hernández; E de Vega-Ríos; J Serrano Ballesteros; D Useros Braña; L Cardeñoso Domingo; A Figuerola Tejerina; D Jiménez Jiménez; I de Los Santos Gil; C Sáez Béjar Journal: Rev Esp Quimioter Date: 2022-01-31 Impact factor: 1.553
Authors: Lisiane Pruinelli; Pranjul Yadav; Andrew Hangsleben; Jakob Johnson; Sanjoy Dey; Maribet McCarty; Vipin Kumar; Connie W Delaney; Michael Steinbach; Bonnie L Westra; György J Simon Journal: AMIA Jt Summits Transl Sci Proc Date: 2016-07-20